关注
Rebecca Kusko
Rebecca Kusko
Cellino
在 cellinobio.com 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Drug repurposing from the perspective of pharmaceutical companies
Y Cha, T Erez, IJ Reynolds, D Kumar, J Ross, G Koytiger, R Kusko, ...
British journal of pharmacology 175 (2), 168-180, 2018
3942018
Transparency and reproducibility in artificial intelligence
B Haibe-Kains, GA Adam, A Hosny, F Khodakarami, ...
Nature 586 (7829), E14-E16, 2020
3512020
Reporting guidelines for human microbiome research: the STORMS checklist
C Mirzayi, A Renson, Genomic Standards Consortium, ...
Nature medicine 27 (11), 1885-1892, 2021
2232021
Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
IW Deveson, B Gong, K Lai, JS LoCoco, TA Richmond, J Schageman, ...
Nature biotechnology 39 (9), 1115-1128, 2021
1582021
The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease
D Ryskamp, J Wu, M Geva, R Kusko, I Grossman, M Hayden, ...
Neurobiology of disease 97, 46-59, 2017
1242017
Integrated genomics reveals convergent transcriptomic networks underlying chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis
RL Kusko, JF Brothers, J Tedrow, K Pandit, L Huleihel, C Perdomo, G Liu, ...
American journal of respiratory and critical care medicine 194 (8), 948-960, 2016
1202016
Leveraging an NQO1 bioactivatable drug for tumor-selective use of poly (ADP-ribose) polymerase inhibitors
X Huang, EA Motea, ZR Moore, J Yao, Y Dong, G Chakrabarti, JA Kilgore, ...
Cancer cell 30 (6), 940-952, 2016
1172016
Pridopidine activates neuroprotective pathways impaired in Huntington Disease
M Geva, R Kusko, H Soares, KD Fowler, T Birnberg, S Barash, ...
Human molecular genetics 25 (18), 3975-3987, 2016
1052016
Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing
W Xiao, L Ren, Z Chen, LT Fang, Y Zhao, J Lack, M Guan, B Zhu, ...
Nature biotechnology 39 (9), 1141-1150, 2021
902021
Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19)
J Kim, J Zhang, Y Cha, S Kolitz, J Funt, R Escalante Chong, S Barrett, ...
Journal of translational medicine 18, 1-9, 2020
842020
PGE2-driven expression of c-Myc and oncomiR-17-92 contributes to apoptosis resistance in NSCLC
K Krysan, R Kusko, T Grogan, J O'Hearn, KL Reckamp, TC Walser, ...
Molecular Cancer Research 12 (5), 765-774, 2014
842014
Similarities and differences between variants called with human reference genome HG19 or HG38
B Pan, R Kusko, W Xiao, Y Zheng, Z Liu, C Xiao, S Sakkiah, W Guo, ...
BMC bioinformatics 20, 17-29, 2019
722019
Quantitative structure–activity relationship models for predicting inflammatory potential of metal oxide nanoparticles
Y Huang, X Li, S Xu, H Zheng, L Zhang, J Chen, H Hong, R Kusko, R Li
Environmental health perspectives 128 (6), 067010, 2020
672020
Structures of endocrine-disrupting chemicals determine binding to and activation of the estrogen receptor α and androgen receptor
H Tan, X Wang, H Hong, E Benfenati, JP Giesy, GC Gini, R Kusko, ...
Environmental Science & Technology 54 (18), 11424-11433, 2020
482020
Premature expression of a muscle fibrosis axis in chronic HIV infection
RL Kusko, C Banerjee, KK Long, A Darcy, J Otis, P Sebastiani, S Melov, ...
Skeletal muscle 2, 1-12, 2012
442012
Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing
LT Fang, B Zhu, Y Zhao, W Chen, Z Yang, L Kerrigan, K Langenbach, ...
Nature biotechnology 39 (9), 1151-1160, 2021
422021
Early pridopidine treatment improves behavioral and transcriptional deficits in YAC128 Huntington disease mice
M Garcia-Miralles, M Geva, JY Tan, NABM Yusof, Y Cha, R Kusko, LJ Tan, ...
JCI insight 2 (23), 2017
422017
Large-scale transcriptomic analysis reveals that pridopidine reverses aberrant gene expression and activates neuroprotective pathways in the YAC128 HD mouse
R Kusko, J Dreymann, J Ross, Y Cha, R Escalante-Chong, ...
Molecular Neurodegeneration 13, 1-15, 2018
372018
The international MAQC Society launches to enhance reproducibility of high-throughput technologies
L Shi, R Kusko, RD Wolfinger, B Haibe-Kains, M Fischer, SA Sansone, ...
Nature biotechnology 35 (12), 1127-1128, 2017
352017
A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis
CJ Ross, F Towfic, J Shankar, D Laifenfeld, M Thoma, M Davis, B Weiner, ...
Genome medicine 9, 1-15, 2017
342017
系统目前无法执行此操作,请稍后再试。
文章 1–20